In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain models

OBJECTIVE: We examined whether it is cost-effective to measure free thyroxine (FT4) in addition to thyrotropin (thyroid-stimulating hormone (TSH)) on all requests for thyroid function tests from primary care on adult patients. BACKGROUND: Hypopituitarism occurs in about 4 people per 100 000 per year...

Descripción completa

Detalles Bibliográficos
Autores principales: Shine, Brian, James, Tim, Adler, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677967/
https://www.ncbi.nlm.nih.gov/pubmed/31362968
http://dx.doi.org/10.1136/bmjopen-2019-029369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677967/
https://www.ncbi.nlm.nih.gov/pubmed/31362968
http://dx.doi.org/10.1136/bmjopen-2019-029369

Ejemplares similares